NRP2 and cancer: In contrast, aNRP2-10 should potentiate radiation therapy more consistently compared with these radiosensitizers, especially given the high expression of NRP2 in TNBC and the inherent need of antioxidant mechanisms for cancer cells to mitigate radiation-induced ROS.